Interferon beta worked really well for me, and now Ocrelizumab is doing even better.
I'm convinced that what we call "Multiple Sclerosis" today is actually a collection of distinct conditions with largely orthogonal causes, and just about the best we can do in absence of a more thorough understanding of the issues is nuke all the adolescent B-lymphocytes (which is what Ocrelizumab does).